BioCentury | Sep 28, 2009
Company News

BurnsAdler, Three Rivers sales and marketing update

...Three Rivers granted BurnsAdler exclusive rights to market Infergen interferon alphacon-1 in Brazil and Chile to...
...markets, except Japan, from Amgen Inc. (NASDAQ:AMGN, Thousand Oaks, Calif.) (see BioCentury, Sept. 22, 2008). BurnsAdler Pharmaceuticals Inc....
BioCentury | Aug 7, 2006
Company News

Innocoll, BurnsAdler sales and marketing update

...Innocoll's Innocoll Pharmaceuticals Ltd. unit granted BurnsAdler rights to distribute CollaRx gentamicin surgical implant to treat...
...Cairo, Egypt), a subsidiary of Schering-Plough Corp. (SGP, Kenilworth, N.J.). Innocoll Inc. , Ashburn, Va. BurnsAdler Pharmaceuticals Inc....
Items per page:
1 - 2 of 2
BioCentury | Sep 28, 2009
Company News

BurnsAdler, Three Rivers sales and marketing update

...Three Rivers granted BurnsAdler exclusive rights to market Infergen interferon alphacon-1 in Brazil and Chile to...
...markets, except Japan, from Amgen Inc. (NASDAQ:AMGN, Thousand Oaks, Calif.) (see BioCentury, Sept. 22, 2008). BurnsAdler Pharmaceuticals Inc....
BioCentury | Aug 7, 2006
Company News

Innocoll, BurnsAdler sales and marketing update

...Innocoll's Innocoll Pharmaceuticals Ltd. unit granted BurnsAdler rights to distribute CollaRx gentamicin surgical implant to treat...
...Cairo, Egypt), a subsidiary of Schering-Plough Corp. (SGP, Kenilworth, N.J.). Innocoll Inc. , Ashburn, Va. BurnsAdler Pharmaceuticals Inc....
Items per page:
1 - 2 of 2